Benitec Biopharma (BNTC) Free Cash Flow (2019 - 2025)
Benitec Biopharma (BNTC) posted Free Cash Flow of -$3.7 million for Q4 2025, down 8.82% sequentially from -$3.4 million in Q3 2025, and up 51.97% YoY from -$2.4 million in Q4 2024.
Benitec Biopharma (BNTC) Free Cash Flow (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Free Cash Flow for 7 years, with the latest figure at -$3.7 million in Q4 2025.
- Quarterly Free Cash Flow rose 51.97% year-over-year to -$3.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$18.4 million (up 15.42% YoY) and the FY2025 annual result came in at -$23.6 million, down 20.63% from the prior year.
- Free Cash Flow declined to -$3.7 million in Q4 2025 per BNTC's latest filing, from -$3.4 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$2.0 million in Q1 2021 and troughed at -$8.2 million in Q2 2025.
- A 5-year average of -$4.6 million and a median of -$4.2 million in 2021 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2021 and 2025: Free Cash Flow slumped 160.6% in 2021, then surged 51.97% in 2025.
- Over 5 years, Free Cash Flow stood at -$3.3 million in 2021, then slumped by 77.42% to -$5.9 million in 2022, then increased by 9.48% to -$5.3 million in 2023, then plunged by 45.34% to -$7.7 million in 2024, then soared by 51.97% to -$3.7 million in 2025.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$3.7 million, -$3.4 million, and -$8.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | -3.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.70 Mn |
| Dec 31, 2025 | -3.70 Mn |
| Sep 30, 2025 | -3.40 Mn |
| Sep 30, 2025 | -3.40 Mn |
| Jun 30, 2025 | -8.23 Mn |
| Jun 30, 2025 | -8.23 Mn |
| Mar 31, 2025 | -3.10 Mn |
| Mar 31, 2025 | -3.10 Mn |
| Dec 31, 2024 | -7.70 Mn |
| Dec 31, 2024 | -7.70 Mn |
| Sep 30, 2024 | -4.59 Mn |
| Sep 30, 2024 | -4.59 Mn |
| Jun 30, 2024 | -3.29 Mn |
| Jun 30, 2024 | -3.29 Mn |
| Mar 31, 2024 | -6.21 Mn |
| Mar 31, 2024 | -6.21 Mn |
| Dec 31, 2023 | -5.30 Mn |
| Dec 31, 2023 | -5.30 Mn |
| Sep 30, 2023 | -4.60 Mn |
| Sep 30, 2023 | -4.60 Mn |